Senior Manager, Global Value, Access & Pricing, Hematology

beigene; Basel; On-site; CHF 150,000 - 210,000; Full time

Job summary

BeOne is seeking an Associate Director to drive global value, access, pricing and reimbursement launch-readiness for our assets across indications and geographies.

You will translate pivotal evidence and payer landscape into differentiated access strategies, collaborating with HEOR, Medical, Regulatory, Commercial and cross-functional teams to optimize reimbursement potential and lifecycle value.

Qualifications

• Bachelor's degree in life sciences, health economics, pharmacy, health policy, business or related field.
• 8+ years biopharmaceutical experience in value, access, pricing and reimbursement.
• Experience developing global pricing and market access strategy for oncology/hematology products, with launch readiness.

Responsibilities

• Support the development of global pricing and reimbursement strategy across indications and regions.
• Build country-ready reimbursement toolkits and JCA dossiers in collaboration with HEOR and cross-functional teams.
• Coordinate with regional access teams to align global tactics with local payer needs and lifecycle planning.

Skills

Global pricing strategy

Market access

HTA knowledge

Cross-functional collaboration

Payer engagement

Education

Bachelor's degree in life sciences/related field

Advanced degree (MSc/MPH/PharmD/PhD/MBA) preferred

Job description

BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.

Purpose of the Role:

Reporting to a Director, GVAP Hematology, the person in this role drives the global value, access, pricing, and reimbursement launch-readiness for an assigned asset - initially in one or more of its early indications, and later potential future pipeline indications - across geographies. The Associate Director translates pivotal evidence and the competitive landscape into a differentiated global access and pricing tactics as well as country-ready toolkits that enable local affiliates to secure timely reimbursement and optimal patient access at launch and across the lifecycle. S/he/they will maintain coordination with other BeOne Hematology portfolio leads whose assets share the same or similar indications and will collaborate closely with global cross-functional teams incl. HEOR, Medical, commercial, clinical development and regulatory as well as seek input and alignment with affiliate teams to develop strategy and access toolkits to optimize the assets reimbursement and pricing potential.

Key Responsibilities:

• Market Access Strategy Development Support: Support the development of global pricing and reimbursement strategy across therapeutic areas/indications, aligned to pivotal evidence and relevant comparators. Support the collection and aggregation of feedback from all regions and develop recommendations for clinical development evidence generation needs. Translate regional and affiliate payer insights into actionable recommendations for clinical development, evidence generation, access strategy, pricing considerations, and commercialization planning. Partner closely with Pricing, HEOR, Medical Affairs, Regulatory Affairs, Commercial, Clinical Development, and regional access teams to align global access and pricing tactics across the asset lifecycle. Provide input into asset lifecycle planning, indication sequencing, and evidence prioritization. Provide input to governance and oversight bodies as delegated. Collaborate cross-functionally to integrate access requirements into the development process, influencing trial design, endpoints, and evidence generation to meet payer needs
• Value Proposition & Evidence Generation: Develop early value propositions that resonate with global payers and support future pricing, reimbursement, and access decisions. Identify and prioritize payer evidence gaps and other data needs to address payer concerns and enhance product differentiation in the indication/therapeutic area. Coordinate with Clinical Development, Regulatory, HEOR, Medical Affairs, Commercial, and regional/country access teams to ensure access needs are incorporated into indication/therapeutic area integrated evidence plans. Provide input into asset lifecycle planning, indication sequencing, and evidence prioritization to maximize long-term access, reimbursement, and portfolio value
• Pre-launch Preparations: Build country-ready reimbursement toolkits in close collaboration with HEOR, including global value dossiers, budget-impact and cost-effectiveness frameworks, and payer communication materials aligned to pivotal evidence and comparators. Lead Joint Clinical Assessment (JCA) dossier development in close collaboration with HEOR, GVAP JCA coordinators, and the wider cross-functional team. Drive global launch and access readiness activities, ensuring milestones, evidence needs, and access deliverables are sequenced to support first and subsequent indication launches. Provide ongoing communication, training, and support to regional and affiliate teams, preparing them to engage effectively with payers as the product nears market entry.
• Market Insights: Monitor relevant therapeutic area competitive, pricing, and policy landscape, translating changes into actionable updates to strategy and toolkits.

Required Qualifications:

• Bachelor's degree in life sciences, health economics, pharmacy, health policy, business, or a related field; advanced degree (MSc, MPH, PharmD, PhD, or MBA) strongly preferred.
• 8+ years of biopharmaceutical experience, with a substantial portion in global (or major-market) value, access, pricing, and reimbursement roles.
• Experience working within a country, regional, or affiliate market access, reimbursement, pricing, or HTA function, with direct exposure to payer decision-making and reimbursement processes, is strongly preferred.
• Demonstrated experience developing global pricing and market access strategy for specialty or oncology/hematology products, ideally including launch readiness.
• Working knowledge of HTA processes and payer systems across key markets (e.g., EU JCA, G-BA/IQWiG, NICE, HAS) and the US payer environment.
• Experience building global value dossie